A fundamental mechanism underlying this process is the interaction between Programmed Death Ligand 1 (PD-L1) on cancer cells and the Programmed Death 1 (PD-1) receptor on cytotoxic T lymphocytes (CTLs), inhibiting T cell activity [2,3,4]. Here, CD274 is linked to cancer.